🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Timothy K. Erick

Dana-Farber Cancer Institute

ORCID: 0000-0002-6855-2528

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “The feasibility of using an autologous GM-CSF-secreting breast cancer vaccine to induce immunity in patients with stage II–III and metastatic breast cancers”.

The feasibility of using an autologous GM-CSF-secreting breast cancer vaccine to induce immunity in patients with stage II–III and metastatic breast cancers

Breast Cancer Research and Treatment(2022)10.1007/s10549-022-06562-y

N/A

0.750DataRank · unranked

23 citations

Timothy K. Erick, Meixuan Chen, Heather Daley, Margaret Campbell, Yolonda L. Colson +8 more

Inflammation-Induced Lactate Leads to Rapid Loss of Hepatic Tissue-Resident NK Cells

Cell Reports(2020)10.1016/j.celrep.2020.107855

N/A

0DataRank · unranked

44 citations

Angela Tata, Timothy K. Erick, Diego Jaime, S. M. Shahjahan Miah, Linda Quatrini +5 more

Preclinical evaluation of an 111In/225Ac theranostic targeting transformed MUC1 for triple negative breast cancer

Theranostics(2020)10.7150/thno.38236

N/A

0DataRank · unranked

43 citations

Shu-ta Wu, Gottumukkala Vijay, Richard Coelho, Keryn Palmer, Surabhi Nair +5 more